Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage
- 1 August 1991
- journal article
- case report
- Published by Elsevier in Surgical Neurology
- Vol. 36 (2), 112-118
- https://doi.org/10.1016/0090-3019(91)90228-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Relationship between cardiac output and cerebral blood flow in patients with intact and with impaired autoregulationJournal of Neurosurgery, 1990
- Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1988
- Preliminary Report: Effects of High Dose Methylprednisolone on Delayed Cerebral Ischemia in Patients at High Risk for Vasospasm after Aneurysmal Subarachnoid HemorrhageNeurosurgery, 1987
- Chronic Cerebral Vasospasm: Effect of Calcium AntagonistsNeurosurgery, 1986
- Effect of selective inhibitor of thromboxane A2 synthetase on experimental cerebral vasospasm.Stroke, 1984
- Treatment of Ischemic Deficits from Vasospasm with Intravascular Volume Expansion and Induced Arterial HypertensionNeurosurgery, 1982
- Considerations in early surgery on good-risk patients with ruptured intracranial aneurysmsJournal of Neurosurgery, 1982
- Relation of Cerebral Vasospasm to Subarachnoid Hemorrhage Visualized by Computerized Tomographic ScanningNeurosurgery, 1980
- Cerebral arterial smooth muscle contraction by thromboxane A2.Stroke, 1977
- Alteration of experimental cerebral vasospasm by adrenergic blockadeJournal of Neurosurgery, 1972